Jennifer Schneider is Director of VERTEX PHARMACEUTICALS INC . Currently has a direct ownership of 922 shares of VRTX, which is worth approximately $430,638. The most recent transaction as insider was on May 15, 2024, when has been sold 922 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 922
0% 3M change
n/a 12M change
Total Value Held $430,638

Jennifer Schneider Transaction History

Date Transaction Value Shares Traded Shares Held Form
May 15 2024
BUY
Grant, award, or other acquisition
-
922 Added 50.0%
922 Common Stock

Also insider at

LVGO
Livongo Health, Inc.
JS

Jennifer Schneider

Director
Mountain View, CA

Track Institutional and Insider Activities on VRTX

Follow VERTEX PHARMACEUTICALS INC and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells VRTX shares.

Notify only if

Insider Trading

Get notified when an Vertex Pharmaceuticals Inc insider buys or sells VRTX shares.

Notify only if

News

Receive news related to VERTEX PHARMACEUTICALS INC

Track Activities on VRTX